email@example.com, firstname.lastname@example.org, "Allen,Marin (NIH/OD) [E]" <AllenM1@mail.nih.gov>, email@example.com, firstname.lastname@example.org, "Strikas,Raymond A. (Ray) (CDC/OID/NCIRD)" <email@example.com>, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, Lawrence.Tabak@nih.gov, email@example.com
Subject: WaPo "On Leadership" and the NIH's Threats for "Asking the Right Question"
Date: May 15, 2012 9:06 AM
Regarding your article on Leadership in WaPo:
We were wondering if you could "ask the right
question" for us to the NIH (Francis Collins
and Anthony Fauci would be fine).
No one at the NIH, CDC, Yale or IDSociety.org
has been able to answer the question of what
exactly the Lyme vaccine (LYMErix or ImmuLyme)
was. Of course we know they were "recombinant
lipoproteins of Outer Surface Protein A of
the Lyme spirochete," but we wanted to know its
***exact structure,*** since as you know, Structure
When I called last Friday (a week ago), Francis
Collins' little secretary would not allow me to
speak - I merely wanted to give her the results of
Collins referrals to others at the NIH to ASK
what was OspA - She instead blurted out that
she would call the police if I kept asking the
NIH what was that vaccine that the CDC and NIH
said was a vaccine:
"We've had an effective vaccine, but it's the kind of vaccine that you have to essentially vaccinate people each year. And from the standpoint of it's use, it has not been used as efficiently as it could have been used. So scientifically, we had a vaccine and still do have a vaccine, but it's not really well used." -- Anthony Fauci
That OspA vaccine was ordered removed from the
market in 2002 when Karen Forschner of the
Lyme Disease Foundation (Hartford, CT) presented
the FDA with a patent owned by Denise Huber at
Tufts indicating that OspA "bound the HLA molecule"
or was technically a toxin for people who have
the (only) genetic background that tests positive for
"Lyme Disease" (as redefined in Dearborn, Michigan
in 1994, in a "consensus" conference held by the
Meanwhile, for the people who do not have the
new, Dearborn, 1994 definition of Lyme "hypersensitivity"
or "binds the HLA molecule" (inferring a binding
of the antigen-presenting molecule with greater
energy or kinetics, producing a toxin, itself
as the complex of HLA-antigen), ***there is another
outcome from the chronic exposure to OspA,*** either
from vaccination (the regimen for the vaccines
experiments was 3 injections of the OspA vaccines)
or from the autovaccination of spirochetal
[Blebbing is to a spirochete what shedding
is to a dog; by merely having a chronic infection
with spirochetes - and all spirochetal infections
throughout history are known to be chronic, a Lyme
victim is subject to this autovaccination or
shedding or blebbing.]
In other words, the other outcomes of chronic
exposure to OspA were the definitions of "Lyme
Disease" that were left out of the Dearborn
"consensus" conference definition - the outcomes
of chronic Lyme previously identified by Yale
and the IDSociety.org in their journal, "Infectious
Disease Reviews," or the New Great Imitator outcomes
of MS, Lupus, ALS, and similar neurological outcomes
that seem to be associated with B cell mutations
that look like Epstein-Barr reactivation.
It turns out that over the years, there is nothing
but more and more additive scientific evidence that
something about this fungal antigen, OspA, mutes the
immune response, produces no antibodies (interferes with
antibody production), and seems to act in synergy
with viruses like Epstein-Barr (EBV), in that both OspA
and EBV either donate to or add to anti-apoptosis of
an infected cell.
Now, meanwhile I remind you that there is no Tuberculosis
vaccine or HIV vaccine, because these vaccines that
were similar to LYMErix produced the same outcomes
as the LYMErix trials: increased susceptibility to
infection and no antibodies.
You can go ahead and look that up or ask someone at
Harvard. I assume there will be someone at Harvard
who can show you how to use the PubMed database.
But, as you know, there is today another outcry apparently
by vaccine manufacturers supported by the CDC [since
the CDC does nothing more than support vaccine
manufacturers, even going so far as to co-own 5
patents with SmithKline in Europe from 1992, wherein
they identify the 2 distinct outcomes of Lyme: 1) the
hypersensitivity or allergy or "bad knees" response
and 2) the non-"bad-knees" response or the cases of
Lyme that do not test positive according to the CDC's
1994, falsified (even if we just judged the outcome
of the conference on the basis of consensus, since
there was no consensus, not even close) Dearborn criteria]
about the high rate of death in children because
there is no Pneumonia vaccine.
Daily Disruption – Study: Pneumonia Leading Cause of Death Among Children Under The Age of 5 -..
Pneumonia is MYCOBACTERIA pneumonia.
No fungal vaccines?
Not whether they were apparently the HIV-LYMErix
or the TB-LYMErix or the MRSA-LYMErix. They all
Now, don't you think it is odd that the NIH and CDC
refuse to answer our question as to what OspA was?
Maybe you could show us some of that Mormon-Harvard
Leadership and ask the right question on our behalf:
"What Is OspA?
Since it failed so many times and is associated
with so many medical failures, not the least of
which are all the myco-contaminated childhood
vaccines that give the result we like to call
1) "Finally, there is the risk that the virus may not be fully or completely inactivated or attenuated and thus, the vaccine may actually cause disease."
2) Measles, Mumps, and Rubella -- Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
"Updated information on adverse events and contraindications, particularly for persons with severe HIV infection, persons with a history of egg allergy or gelatin allergy, persons with a history of thrombocytopenia, and persons receiving steroid therapy [are immunosuppressed- KMD]."
3) CDC: Human Exposure to Brucella abortus Strain RB51 -- Kansas, 1997
An ^^^ immunosuppressed pregnant cow was given a Brucella (LYMErix-like) "live attenuated" vaccine and the baby cow ended up with the disease, which then was transferred to the humans handling the cow and her dead baby. This parallels what is happening to children who are vaccinated while immunosuppressed, or who receive mycoplasmally (LYMErix-like) contaminated vaccines.
4) in the case of pandemic MRSA, as we have seen, the vaccine didn't work because TLR2 agonists (lipoproteins) suppress the immune system. We also learned from the MRSA vaccine patent, that:
"Several established vaccines consist of live attenuated organisms where ***the risk of reversion to the virulent wild-type strain exists. In particular in immunocompromised hosts this can be a live threatening scenario.*** Alternatively, vaccines are administered as a combination of pathogen-derived antigens together with compounds that induce or enhance immune responses against these antigens (these compounds are commonly termed adjuvant), since these subunit vaccines on their own are generally not effective."
WaPo and the Harvard Business School and
the Mormons call this Leadership. When
American Government's Crime Victims
ask the right question, we're thrown and
jail and threatened with jail.
This is the opposite of leadership, but
I hope you can put your money where your
Mormon/HBS mouth is and ask Francis Collins
what OspA is and get back to us.
Kathleen M. Dickson
former Pfizer Analytical Methods
and Validations chemist